10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,913,537 | +59.6% | 88,072 | +4.3% | 0.43% | +74.4% |
| Q4 2022 | $3,078,305 | +68.7% | 84,476 | +31.9% | 0.25% | +58.7% |
| Q3 2022 | $1,825,000 | -46.7% | 64,064 | -15.3% | 0.16% | -46.6% |
| Q2 2022 | $3,421,000 | -44.0% | 75,594 | -5.8% | 0.29% | -39.5% |
| Q1 2022 | $6,107,000 | -73.7% | 80,276 | -48.5% | 0.48% | -67.7% |
| Q4 2021 | $23,231,000 | +11.8% | 155,952 | +9.2% | 1.48% | +14.9% |
| Q3 2021 | $20,784,000 | +3.1% | 142,772 | +38.7% | 1.29% | +26.3% |
| Q2 2021 | $20,153,000 | +12.4% | 102,914 | +3.9% | 1.02% | -14.1% |
| Q1 2021 | $17,930,000 | – | 99,061 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |